Z0878

Zaprinast

solid

• Synonym(e): 1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one
• Empirische Formel (Hill-System): C₁₃H₁₃N₅O₂
• CAS-Nummer: 37762-06-4
• Molekulargewicht: 271.27
• EG-Nummer: 253-655-1
• MDL-Nummer: MFCD00214073
• UNSPSC-Code: 12352202
• PubChem Substanz-ID: 24278072
• NACRES: NA.77

Eigenschaften

• Form: solid
• Qualitätsniveau: 200
• Farbe: white
• Löslichkeit: 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.11 mg/mL; DMSO: 10 mg/mL; H₂O: insoluble
• SMILES String: CCCOc1ccccc1C2=NC(=O)c3nn[nH]c3N2
• InChI: 1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)
• InChIKey: REZGGXNDEMKIQB-UHFFFAOYSA-N
• Angaben zum Gen: human ... PDE2A(5138) , PDE4A(5141) , PDE4B(5142) , PDE4D(5144)

Beschreibung

Anwendung

Zaprinast has been used to determine its inhibitory effect on the meiosis of oocytes by germinal vesicle breakdown (GVBD) assay and to test the inhibitory effect of it on the retinal cells by immunohistochemistry.

Biochem./physiol. Wirkung

Zaprinast insubstantially inhibits phosphodiesterase 10 and 11 (PDE10 and PDE11). It also exhibits vasodilating effects.

Selective inhibitor of cGMP-specific phosphodiesterases V and VI (PDE5/6) and an agonist at the G protein-coupled receptor 35 (GPR35).

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H315,H319,H335
• P-Sätze: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: dust mask type N95 (US), Eyeshields, Gloves